For the Inventor, By the Inventor

Enter assignee name

Aliso Viejo, CA, United States of America

Avanir Pharmaceuticals

USPTO Granted Patents = 38

CIPO Patents = 4

EPO Patents = 4

Trademarks = 11

Forward Citations = 587

Loading Chart...

Loading Chart...

34 inventors (with patents filed for the assignee):

Jagadish C Sircar (28 out of 36 patents)

Wenbin Ying (19 out of 54 patents)

Sunil Kumar K C (14 out of 23 patents)

4. Robert Z Florkiewicz (13 out of 25 patents)

5. Federico C A Gaeta (13 out of 24 patents)

6. Jerry Anchin (13 out of 14 patents)

7. Andrew J Baird (13 out of 36 patents)

8. Mark L Richards (9 out of 11 patents)

9. Laura E Pope (6 out of 8 patents)

10. Michael W Major (5 out of 7 patents)

11. Michael G Campbell (5 out of 15 patents)

12. Sunil Kumar Kc (4 out of 124 patents)

13. Matt Johnson (4 out of 4 patents)

14. Cunxiang Zhao (4 out of 4 patents)

15. Weihua Meng (4 out of 4 patents)

38 patents: Sort by Forward Citations

1. 12291505 - Methods for the synthesis of deuterated dextromethorphan (2025-05-06),

2. 11845731 - Methods for the synthesis of deuterated dextromethorphan (2023-12-19),

3. 10865187 - Methods for the synthesis of deuterated dextromethorphan (2020-12-15),

4. 10730841 - Methods for the synthesis of deuterated dextromethorphan (2020-08-04),

5. 8227484 - Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (2012-07-24),

6. 7732146 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2010-06-08),

7. 7659282 - Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (2010-02-09),

8. 7514225 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2009-04-07),

9. 7432374 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2008-10-07),

10. 7375118 - Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation (2008-05-20),

11. 7365200 - Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors (2008-04-29),

12. 7361760 - Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases (2008-04-22),

13. 7312221 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-12-25),

14. 7312220 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-12-25),

15. 7282518 - Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation (2007-10-16),

Avanir Pharmaceuticals is a pharmaceutical company specializing in the development of innovative therapies for central nervous system disorders. With a focus on neurological conditions, Avanir strives to improve the lives of patients through cutting-edge research, advanced technology, and compassionate care. Their commitment to addressing unmet medical needs has made them a trusted provider of effective treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

38 Patents

#11 in Aliso Viejo, CA

#2,068 in California

#8,722 in US

#17,288 in the World

Aliso Viejo, CA, United States of America

Avanir Pharmaceuticals

Forward Citations = 587

34 inventors:

Jagadish C Sircar (28 out of 36 patents)

Wenbin Ying (19 out of 54 patents)

Sunil Kumar K C (14 out of 23 patents)

4. Robert Z Florkiewicz (13 out of 25 patents)

5. Federico C A Gaeta (13 out of 24 patents)

Please report any incorrect information to support@idiyas.com

Loading…